4.3 Article

Cas9-Mediated Gene-Editing in the Malaria Mosquito Anopheles stephensi by ReMOT Control

期刊

G3-GENES GENOMES GENETICS
卷 10, 期 4, 页码 1353-1360

出版社

GENETICS SOCIETY AMERICA
DOI: 10.1534/g3.120.401133

关键词

CRISPR; Cas9; ovary translocation; reverse genetics

资金

  1. NSF/BIO [1645331]
  2. NIH/NIAID [R21AI111175, R01AI128201, R21AI138074, R21AI129507, R01AI29746]
  3. USDA/NIFA [2014-10320, 2017-67012-26101]
  4. USDA Hatch funds [1010032, PEN04608]
  5. Pennsylvania Department of Health using Tobacco Settlement Funds
  6. Wolfson Foundation
  7. Royal Society fellowship [RSWF\R1\180013]
  8. John S. Dunn Foundation Collaborative Research Award
  9. Fulbright Fellowship
  10. Colciencias

向作者/读者索取更多资源

Innovative tools are essential for advancing malaria control and depend on an understanding of molecular mechanisms governing transmission of malaria parasites by Anopheles mosquitoes. CRISPR/Cas9-based gene disruption is a powerful method to uncover underlying biology of vector-pathogen interactions and can itself form the basis of mosquito control strategies. However, embryo injection methods used to genetically manipulate mosquitoes (especially Anopheles) are difficult and inefficient, particularly for non-specialist laboratories. Here, we adapted the ReMOT Control (Receptor-mediated Ovary Transduction of Cargo) technique to deliver Cas9 ribonucleoprotein complex to adult mosquito ovaries, generating targeted and heritable mutations in the malaria vector Anopheles stephensi without injecting embryos. In Anopheles, ReMOT Control gene editing was as efficient as standard embryo injections. The application of ReMOT Control to Anopheles opens the power of CRISPR/Cas9 methods to malaria laboratories that lack the equipment or expertise to perform embryo injections and establishes the flexibility of ReMOT Control for diverse mosquito species.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据